Medeon Biodesign, Inc.(TW:6499)
NT$73.80-2.00 (-2.64%)
TW:6499
Medeon Biodesign, Inc. financials statements
NT$73.80
At close:-2.00 (-2.64%)
Medeon Biodesign, Inc. (6499) Income Statement
Medeon Biodesign, Inc. Income Statement
Last quarter (Q2 2026), Medeon Biodesign, Inc.'s total revenue was NT$106.61M, a decrease of 3.42% from the same quarter last year. In Q2, Medeon Biodesign, Inc.'s net income was NT$-124.77M. See Medeon Biodesign, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 419.43M | NT$ 292.81M | NT$ 196.26M | NT$ 298.32M | NT$ 68.96M | |
| NT$ 58.83M | NT$ 83.41M | NT$ -65.20M | NT$ 186.81M | NT$ 28.63M | |
| NT$ 781.34M | NT$ 955.62M | NT$ 774.37M | NT$ 674.65M | NT$ 524.22M | |
| Depreciation and Amortization | NT$ 107.36M | NT$ 98.66M | NT$ 95.67M | NT$ 63.80M | NT$ 59.02M |
| NT$ -615.15M | NT$ -754.42M | NT$ -1.14B | NT$ -370.10M | NT$ -453.87M | |
| NT$ -722.51M | NT$ -872.20M | NT$ -838.99M | NT$ -487.84M | NT$ -512.88M | |
| NT$ 2.82M | NT$ 26.97M | NT$ -391.70M | NT$ 48.72M | NT$ -20.69M | |
| NT$ -719.69M | NT$ -858.64M | NT$ -1.24B | NT$ -439.12M | NT$ -513.91M | |
| NT$ -668.06M | NT$ -805.51M | NT$ -1.20B | NT$ -433.76M | NT$ 2.08B | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -7.24 | NT$ -8.74 | NT$ -13.09 | NT$ -4.71 | NT$ 22.65 |
| Diluted EPS | NT$ -7.24 | NT$ -8.74 | NT$ -13.09 | NT$ -4.71 | NT$ 22.57 |
| Weighted Average Shares Outstanding | 92.27M | 92.19M | 92.03M | 92.02M | 91.75M |
| Weighted Average Shares Outstanding (Diluted) | 92.27M | 92.19M | 92.03M | 92.02M | 92.08M |
Currency in TWD

